0001818382-22-000222.txt : 20221219
0001818382-22-000222.hdr.sgml : 20221219
20221219202523
ACCESSION NUMBER: 0001818382-22-000222
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221215
FILED AS OF DATE: 20221219
DATE AS OF CHANGE: 20221219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dougan Brady W
CENTRAL INDEX KEY: 0001878020
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39532
FILM NUMBER: 221472649
MAIL ADDRESS:
STREET 1: 35 WILSHIRE ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06831
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Humacyte, Inc.
CENTRAL INDEX KEY: 0001818382
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851763759
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919-313-9633
MAIL ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER COMPANY:
FORMER CONFORMED NAME: Alpha Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20200716
4
1
wf-form4_167149950807724.xml
FORM 4
X0306
4
2022-12-15
0
0001818382
Humacyte, Inc.
HUMA
0001878020
Dougan Brady W
2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM
NC
27713
1
0
1
0
Common Stock
2022-12-15
4
P
0
10000
2.54
A
1170240
I
By spouse
Common Stock
17990736
I
By Ayabudge LLC
Common Stock
510161
D
This purchase by the Reporting Person's spouse is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person, of 1,522,500 shares of the Issuer's common stock on September 15, 2022, at a per share price of $4.00. The Reporting Person's spouse has paid the Issuer $14,604.95, representing the full amount of profit realized in connection with this purchase.
The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $2.53 to $2.55. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
2022-12-19